Lozovaya, N.
Eftekhari, S.
Cloarec, R.
Gouty-Colomer, L. A.
Dufour, A.
Riffault, B.
Billon-Grand, M.
Pons-Bennaceur, A.
Oumar, N.
Burnashev, N.
Ben-Ari, Y.
Hammond, C.
Article History
Received: 19 September 2017
Accepted: 9 March 2018
First Online: 12 April 2018
Competing interests
: N.L., S.E., R.C., L.A.G.-C., A.D., B.R., M.B.-G., N.O., and Y.B.-A. are salaried of Neurochlore or B&A Therapeutics. N.L., N.B., Y.B.-A., and C.H. are shareholders of Neurochlore. Y.B.-A. is CEO of Neurochlore and B&A Therapeutics. A.P.-B. declares no competing interests.